preamble_23
Whereas the Agency should also be responsible for coordinating the activities of the Member States in the field of the monitoring of adverse reactions to medicinal products (pharmacovigilance);
← preamble_22 · All articles · preamble_24 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.